Anxiety and Depression in Epilepsy: A Treatment Study
Status:
Completed
Trial end date:
2019-09-20
Target enrollment:
Participant gender:
Summary
As a potential solution to address high rates of depression and anxiety seen in epilepsy
patients and poor mental health care access, this randomized trial aims to study treatment
for anxiety and depression in epilepsy taking place directly within the epilepsy clinic vs.
psychiatry referral (typical care). Patients that meet eligibility criteria, including
significant symptoms of depression and/or anxiety, will be randomized to the either the
intervention group or the control group. Patients that do not meet eligibility requirement or
decline the study intervention will have the option of participating in the survey arm of the
study. The intervention will consist of an initial prescription for an FDA-approved
medication to treat depression/anxiety and telephone-based chronic care management plan for
repeated symptom measurement and side effect surveillance. The control group will receive
usual care, which is a referral order to psychiatry placed by their treating neurologist.
Participants in the survey arm of the study will complete a one time survey.